| Julie Phipps, | |
|
2498 Dayton Xenia Rd, Beavercreek, OH 45434-7169 | |
| (937) 427-1919 | |
| (937) 427-1949 |
| Full Name | Julie Phipps |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2498 Dayton Xenia Rd, Beavercreek, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407231814 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT4633 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julie Phipps, 2498 Dayton Xenia Rd, Beavercreek, OH 45434-7169 Ph: () - | Julie Phipps, 2498 Dayton Xenia Rd, Beavercreek, OH 45434-7169 Ph: (937) 427-1919 |
News Archive
KaloBios Pharmaceuticals, Inc. today announced an agreement with Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, for the development and commercialization of KB001, an investigational new biologic for the treatment or prevention of Pseudomonas aeruginosa (Pa) infections. Sanofi Pasteur will be responsible for the development and commercialization of KB001 and initially focus on hospital indications, including the prevention of Pa pneumonias in mechanically ventilated patients.
Mendor, the Finnish diabetes technology company, continues its rapid growth and is excited to announce yet another international partnership - now opening the United Kingdom for its innovative products. Mendor has just signed a distribution agreement with a leading pharmaceutical company in the Diabetes field Merck Serono, covering the United Kingdom diabetes market.
A new study published on the preprint server medRxiv* in September 2020 describes the measurement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins in wastewater as a reliable way to track the virus in the community.
Systemic lupus erythematosus (SLE) is disease in which the immune system mistakenly attacks healthy tissues, resulting in inflammation and tissue damage. Current treatments are focused on suppression of the immune system, but these therapies can leave patients vulnerable to infection.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in the pivotal trial to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery disease.
› Verified 4 days ago
Claire Colwell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3817 Colonel Glenn Hwy, Beavercreek, OH 45324 Phone: 937-427-9200 Fax: 513-755-3762 | |
Michaela Novotny, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3817 Colonel Glenn Hwy, Beavercreek, OH 45324 Phone: 937-427-9200 | |
Emily Morgan Kocjan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2498 Dayton Xenia Rd, Beavercreek, OH 45434 Phone: 937-427-1919 | |
Amanda Klotter, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3817 Colonel Glenn Hwy, Beavercreek, OH 45324 Phone: 937-427-9200 | |
Ms. Cynthia Ann Bunting Preston, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3817 Colonel Glenn Hwy, Beavercreek, OH 45324 Phone: 937-427-9200 Fax: 513-755-3762 | |
Elizabeth Huber, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2498 Dayton Xenia Rd, Beavercreek, OH 45434 Phone: 937-427-1919 Fax: 937-427-1949 | |
Samantha Hughes, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3817 Colonel Glenn Hwy, Beavercreek, OH 45324 Phone: 937-427-9200 |